medigraphic.com
Órgano Oficial de la Sociedad Mexicana de Angiología y Cirugía Vascular

2013, Number 1

<< Back Next >>

Rev Mex Angiol 2013; 41 (1)

Interrupción de la vena cava inferior. Otras indicaciones. 22 años de experiencia. Estudio multicéntrico

Bizueto-Rosas H, Linarte-Márquez LC, Salazar-Flores CA, Cruz-Castillo JE, Vidal-Vallejo A, Hernández-Pérez NA

Language: Spanish
References: 32
Page: 6-14
PDF size: 243.15 Kb.


ABSTRACT

Material and methods: We analyze other causes for inferior vena cava interruption, such as: filter placement after a first embolic event in patients with severe pulmonary hypertension and cardiopulmonary repercussion. In patients with APS the risk of developing pulmonary embolism is up to 34% even with anticoagulants and platelet antiagregants. Multicenter, ambispective, observational, descriptive and transversal study, from october 1989 to april 2012. We studied the complications after placement vena cava filter and also the frequency of those complications in these patients. Statistical analysis: descriptive statistics.
Results: We included 173 patients. There were 7 extraluminal procedures and insertion of 165 filters. 122 female and 51 male. One female patient with unsuccessful placement. 106 patients with severe pulmonary arterial hypertension. 50 with pulmonary embolism despite anticoagulation. 17 profilactic placements. Mortality rate of 1.15%. 162 insertions under local anesthesia and intravenous sedation. 10 subarachnoid block and intravenous sedation. 91 right jugular placement, 4 left jugular. 60 right femoral. 8 left femoral. 22 with vein dissection. And 3 cases with vena cava direct approach. We perform cavography in 90% of the patients to corroborate the filter place and also the vena cava permeability.
Conclusions: Vena cava filter placement is safe in APS patients with hemodynamic repercussion and also in prophylaxis. The filter insertion is justified because of the high mortality rate at the second event. Not having an increase incidence of in situ or cava vein thrombosis.


REFERENCES

  1. Barrit DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled study. Lancet 1960; 1: 1309-12.

  2. Wagenvoort CA. Pathology of pulmonary thromboembolism. Chest 1995; 107: 10S-10S7.

  3. Munier N, Edwin Ch. Complications of inferior vena cava filters: A single-Center Experience. Ann Vasc Surg 2010; 24: 480-6.

  4. Hann Christine L, Streiff Michael B. The role of vena cava filters in the management of venous thromboembolism. Blood Reviews 2005; 19: 179-202.

  5. Aziz F, Spate K, Wong J, Aruny J, Sumpio B. Revisión de la experiencia en un único centro de trauma. Cambio de patrones en el uso de los filtros de la vena cava inferior. J Am Coll Surg 2007; 205: 564-9

  6. Miles RM, Elsea PW. Clinical evaluation of the serrated vena caval clip. Surg Gynecol Obstet 1971; 132(4): 581-7.

  7. Rojas GA, Cervantes J, Decanini A, Hernández B. Evolución histórica de la interrupción quirúrgica de la vena cava. Experiencia de los autores. An Med Asoc Med Hosp ABC 2003; 48(4): 210-5.

  8. Eichelter P, Schenk W. Prophylaxis of pulmonary embolism. A new experimental approach with initial results. Arch Surg 1968; 97: 348.

  9. Mobin-Uddin K, Smith PE, Martinez LD. A vein cava filter for the prevention of pulmonary embolism. Surg Forum 1967; 18: 209-11.

  10. Greenfield LJ, McCurdy Jr, Brown PP, Elkins RC. A new intracaval filter permitting continued flow and resolution of emboli. Surgery 1973; 73: 599-606.

  11. Rojas G, Enríquez E, Garmilla J, Gerson R, Varela M. Un nuevo filtro de Greenfield de titanio para la interrupción endovascular percutánea de la vena cava inferior. An Med Asoc Med Hosp ABC 1992; 37: 75-8.

  12. Streiff M. Filtro de vena cava. Revisión. Blood 2000; 95: 3669-77.

  13. Greenfield LJ, Proctor MC. Twenty years clinical experience with the Greenfield filter. Cardiovasc Surg 1995; 3: 199-205.

  14. Gutiérrez CR, Sánchez FC, Ramírez MJ, Sauma RS, Morales MC, et al. Interrupción del flujo en la vena cava inferior por embolia pulmonar. Rev Mex Angiol 1995; 23: 38-42.

  15. Rojas G, Cervantes J, Arcos L, Ponte R, Galicia JA. Empleo del filtro de Greenfield en posición suprarrenal. Cir Ciruj 1996; 64: 102-7.

  16. Rojas G, Ponte R, Gerson R, Cervantes J, Flores C. Filtro de Greenfield en vena cava superior. Informe del primer caso reportado en la literatura nacional. Rev Mex Angiol 1997; 25: 93-7.

  17. Cho KJ, Greenfield LJ, Proctor MC, et al. Evaluation of a new percutaneous stainless steel Greenfield filter. J Vasc Interv Radiol 1997; 8: 181-7.

  18. Pomper SR, Lutchman G. The role of intracaval filters in patients with COPD and DVT. Angiology 1991; 42: 85-9.

  19. Cohen J, Tenenbaum M, Citron M. Greenfield filter as primary therapy for deep venous thrombosis and/or pulmonary embolism in patients with cancer. Surgery 1991; 109: 12-5.

  20. Rojas G, Gerson R, Cervantes J, Arcos L, Villalobos A, Ponte R. Trombosis venosa profunda y/o tromboembolismo pulmonar en el paciente oncológico. Rev Inst Nal Cancerol (Mex) 1996; 42: 92-6.

  21. Chan A, Woodruff RK. Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy. Aust NZJ Med 1992; 22: 119-22.

  22. Hicks MF, Dorfman GS. Vena cava filters. Vascular Diseases- Surgical and Interventional Therapy. Vol. 2. Churchill Livingstone Inc.; 1994, p. 1017-44.

  23. Vaughn B, Knezevich S, Lombardi A, Mallory T. Use of the Greenfield filter to prevent fatal pulmonary embolism associated with total hip and knee arthroplasty. J Bone Joint Surg 1989; 71: 1542-48.

  24. Khansarinia S, Dennis J, Veldenz H, Butcher JL, Hartland L. Prophylactic Greenfield filter placement in selected highrisk trauma patients. J Vasc Surg 1995; 22: 231-6.

  25. Kazmers A, Jacobs L, Perkins A. Pulmonary embolism in veterans affairs medical centers: in vena cava interruption under utilized. Am Surg 1999; 65: 1171-5.

  26. Rojas G, Cervantes J, Álvarez AC, Enríquez E, Ponte R, et al. Cinco años de experiencia clínica con el filtro de Greenfield. Cir Ibero Amer (Madrid) 1994; 2: 94-9.

  27. Stewart JR, Peyton JW, Crute SL, Greenfield LJ. Clinical results of suprarenal placement of the Greenfield vena cava filter. Surgery 1992; 92: 1-4.

  28. Henke P, Varma M, Proctor M, Greenfield LJ. Suprarenal Greenfield vena caval filter placement. The Ann Arbor Experience. In: ST Yao J, Pearce WH. Modern vascular surgery. New York, NY: McGraw Hill; 2000.

  29. Berry R, George J, Shaver W. Free-floating deep venous thrombosis. Ann Surg 1990; 211: 719-23.

  30. Rohrer MJ, Scheidler MG, Wheeler B, Cutler BS. Extended indications for placement of an inferior vena cava filter. J Vasc Surg 1989; 10: 44-50.

  31. Rubenfire M, Bayram M, Hector-Word Z. Pulmonary hypertension in the critical care setting: Classification, pathophysiology, diagnosis, and management. Crit Care Clin 2007; 23: 801-34.

  32. Rivera FC. Cancún Quintana Roo: Simposio Internacional Enfermedad tromboembólica venosa; 2012, p. 12.




2020     |     www.medigraphic.com